张艺馨，邵瑞飞，陈国兵. 硫氧还蛋白在脓毒症中的作用研究进展[J]. 中国急救医学, 2019, 39(9): 898-901.
Zhang Yi-xin, Shao Rui-fei, Chen Guo-bing. Research progress of thioredoxin in sepsis. Chinese Journal of Critical Care Medicine, 2019, 39(9): 898-901.
［1］Cecconi M, Evans L, Levy M, et al. Sepsis and septic shock［J］. Lancet, 2018, 392(10 141):75-87.
［2］van der Poll T, van de Veerdonk FL, Scicluna BP, et al. The immunopathology of sepsis and potential therapeutic targets［J］. Nat Rev Immunol, 2017, 17(7):407-420.
［3］李俊杰,尹文. 感染性休克临床治疗的研究进展［J］. 中国急救医学, 2015, 35(4)：289-296.
［4］Christaki E, Anyfanti P, Opal SM. Immunomodulatory therapy for sepsis: an update［J］. Expert Rev Anti Infect Ther, 2011, 9（11）:1013-1033.
［5］Balsera M, Buchanan BB. Evolution of the thioredoxin system as a step enabling adaptation to oxidative stress［J］. Free Radic Biol Med, 2019, 9: 32 638.
［6］Collet JF, Messens J. Structure, function, and mechanism of thioredoxin proteins［J］. Antioxid Redox Signal, 2010, 13(8):1205-1216.
［7］Shang W, Xie Z, Lu F, et al. Increased thioredoxin-1 expression promotes cancer progression and predicts poor prognosis in patients with gastric cancer［J］. Oxid Med Cell Longev, 2019, 2019:9 291 683.
［8］Léveillard T, At-Ali N. Cell signaling with extracellular thioredoxin and thioredoxin-Like proteins: insight into their mechanisms of action［J］. Oxid Med Cell Longev, 2017, 2017:8 475 125.
［9］Nakamura H, Hoshino Y, Okuyama H, et al. Thioredoxin 1 delivery as new therapeutics［J］. Adv Drug Deliv Rev, 2009, 61(4):303-309.
［10］Ueda S, Nakamura T, Yamada A, et al. Recombinant human thioredoxin suppresses lipopolysaccharide-induced bronchoalveolar neutrophil infiltration in rat［J］. Life Sci, 2006, 79(12):1170-1177.
［11］Hoshino T, Nakamura H, Okamoto M, et al. Redox-active protein thioredoxin prevents proinflammatory cytokine- or bleomycin-induced lung injury［J］. Am J Respir Crit Care Med, 2003, 168(9):1075-1083.
［12］Yashiro M, Tsukahara H, Matsukawa A, et al. Redox-active protein thioredoxin-1 administration ameliorates influenza a virus(H1N1)-induced acute lung injury in mice［J］. Crit Care Med, 2013, 41(1):171-181.
［13］Marotta F, Chui DH, Jain S, et al. Effect of a fermented nutraceutical on thioredoxin level and TNF-alpha signalling in cirrhotic patients［J］. J Biol Regul Homeost Agents, 2011, 25(1):37-45.
［14］Das KC, Kundumani-Sridharan V, Subramani J. Role of Thioredoxin in Age-Related Hypertension［J］. Curr Hypertens Rep, 2018, 20(1): 6.
［15］Okuyama H, Nakamura H, Shimahara Y, et al. Overexpression of thioredoxin prevents acute hepatitis caused by thioacetamide or lipopolysaccharide in mice［J］. Hepatology, 2003, 37(5):1015-1025.
［16］Callister ME, Burke-Gaffney A, Quinlan GJ, et al. Extracellular thioredoxin levels are increased in patients with acute lung injury［J］. Thorax, 2006, 61(6):521-527.
［17］Mongardon N, Lemiale V, Borderie D, et al. Plasma thioredoxin levels during post-cardiac arrest syndrome: relationship with severity and outcome［J］. Crit Care, 2013, 17(1):R18.
［18］Leaver SK, Maccallum NS, Pingle V, et al. Increased plasma thioredoxin levels in patients with sepsis: positive association with macrophage migration inhibitory factor［J］. Int Care Med, 2010, 36(2):336-341.
［19］Eriksson J, Gidlf A, Eriksson M, et al. Thioredoxin a novel biomarker of post-injury sepsis［J］. Free Radic Biol Med, 2017, 104:138-143.
［20］Hofer S, Rosenhagen C, Nakamura H, et al. Thioredoxin in human and experimental sepsis［J］. Crit Care Med, 2009, 37(7):2155-2159.
［21］Bahar I, Elay G, Bakol G, et al. Increased DNA damage and increased apoptosis and necrosis in patients with severe sepsis and septic shock［J］. J Crit Care, 2018, 43:271-275.
［22］Chen G, Li X, Huang M, et al. The role of thioredoxin-1 in suppression sepsis through inhibiting mitochondrial-induced apoptosis in spleen［J］. Shock, 2017, 47(6):753-758.
［23］Almanza A, Carlesso A, Chintha C, et al. Endoplasmic reticulum stress signalling-from basic mechanisms to clinical applications［J］. FEBS J, 2019, 286(2):241-278.
［24］Wang M, Kaufman RJ. Protein misfolding in the endoplasmic reticulum as a conduit to human disease［J］. Nature, 2016, 529(7586):326-335.
［25］尹雪莲. 内质网应激与常见危重症［J］. 中国急救医学, 2011, 31(6)：551-554.
［26］Khan MM, Yang WL, Wang P. Endoplasmic reticulum stress in sepsis［J］. Shock, 2015, 44(4):294-304.
［27］Hiramatsu N, Kasai A, Hayakawa K, et al. Real-time detection and continuous monitoring of ER stress in vitro and in vivo by ES-TRAP: evidence for systemic, transient ER stress during endotoxemia［J］. Nucleic Acids Res, 2006, 34(13):e93.
［28］Ma T, Han L, Gao Y, et al. The endoplasmic reticulum stress-mediated apoptosis signal pathway is involved in sepsis-induced abnormal lymphocyte apoptosis［J］. Eur Surg Res, 2008, 41(2):219-225.
［29］Chen G, Li X, Huang M, et al. Thioredoxin-1 increases survival in sepsis by inflammatory response through suppressing endoplasmic reticulum stress［J］. Shock, 2016, 46(1):67-74.
［30］Verfaillie T, Garg AD, Agostinis P. Targeting ER stress induced apoptosis and inflammation in cancer［J］. Cancer Lett, 2013, 332(2):249-264.
［31］Mohammed-Ali Z, Cruz GL, Dickhout JG. Crosstalk between the unfolded protein response and NF-kappaB-mediated inflammation in the progression of chronic kidney disease［J］. J Immunol Res, 2015, 2015:428 508.
［32］Garg AD, Kaczmarek A, Krysko O, et al. ER stress-induced inflammation: does it aid or impede disease progression［J］. Trends Mol Med, 2012, 18(10):589-598.
［33］Wilson RL, Selvaraju V, Lakshmanan R, et al. Thioredoxin-1 attenuates sepsis-induced cardiomyopathy after cecal ligation and puncture in mice［J］. J Surg Res, 2017, 220:68-78.
［34］Yodoi J, Matsuo Y, Tian H, et al. Anti-inflammatory thioredoxin family proteins for medicare, healthcare and aging care［J］. Nutrients, 2017, 9(10): E1081.
